These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Bonnefoy A; Daenens K; Feys HB; De Vos R; Vandervoort P; Vermylen J; Lawler J; Hoylaerts MF Blood; 2006 Feb; 107(3):955-64. PubMed ID: 16204318 [TBL] [Abstract][Full Text] [Related]
3. Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura. Banno F; Kokame K; Okuda T; Honda S; Miyata S; Kato H; Tomiyama Y; Miyata T Blood; 2006 Apr; 107(8):3161-6. PubMed ID: 16368888 [TBL] [Abstract][Full Text] [Related]
4. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy. Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821 [TBL] [Abstract][Full Text] [Related]
5. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner. Bao J; Xiao J; Mao Y; Zheng XL Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063 [TBL] [Abstract][Full Text] [Related]
6. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura. Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235 [TBL] [Abstract][Full Text] [Related]
7. Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13. Tersteeg C; Fijnheer R; Pasterkamp G; de Groot PG; Vanhoorelbeke K; de Maat S; Maas C Semin Thromb Hemost; 2016 Feb; 42(1):9-17. PubMed ID: 26595154 [TBL] [Abstract][Full Text] [Related]
8. [ADAMTS13, von Willebrand factor specific cleaving protease]. Veyradier A; Coppo P Med Sci (Paris); 2011 Dec; 27(12):1097-105. PubMed ID: 22192749 [TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Tsai HM J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148 [TBL] [Abstract][Full Text] [Related]
10. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. George JN Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond. Lian EC Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413 [TBL] [Abstract][Full Text] [Related]
12. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies. Soejima K; Nakagaki T Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617 [TBL] [Abstract][Full Text] [Related]
13. Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura. Deforche L; Tersteeg C; Roose E; Vandenbulcke A; Vandeputte N; Pareyn I; De Cock E; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K PLoS One; 2016; 11(8):e0160388. PubMed ID: 27479501 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in thrombotic thrombocytopenic purpura. Sadler JE; Moake JL; Miyata T; George JN Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695 [TBL] [Abstract][Full Text] [Related]
16. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall. Rybaltowski M; Suzuki Y; Mogami H; Chlebinska I; Brzoska T; Tanaka A; Banno F; Miyata T; Urano T Pflugers Arch; 2011 Jun; 461(6):623-33. PubMed ID: 21494805 [TBL] [Abstract][Full Text] [Related]
17. Formation and Resolution of Pial Microvascular Thrombosis in a Mouse Model of Thrombotic Thrombocytopenic Purpura. Adili R; Holinstat M Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1817-1830. PubMed ID: 31340669 [TBL] [Abstract][Full Text] [Related]
18. Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura. Tsai HM Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):388-96. PubMed ID: 12615692 [TBL] [Abstract][Full Text] [Related]
19. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Furlan M; Lämmle B Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108 [TBL] [Abstract][Full Text] [Related]
20. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene]. Schiphorst RH; van de Kar NC; van den Heuvel LP Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]